<DOC>
	<DOCNO>NCT01924962</DOCNO>
	<brief_summary>The study randomise comparison recanalisation chronic occlude coronary artery implantation Sirolimus elute stent medical therapy . Myocardial function scar-size determinated use magnetic resonance imaging . The study hypothesis superiority medical therapy revascularisation .</brief_summary>
	<brief_title>Recovery Left Ventricular Function Chronic Total Occluded Coronary Arteries</brief_title>
	<detailed_description>In REVASC-study recovery leave ventricular function recanalization chronic total coronary occlusion ( CTO ) implantation sirolimus-eluting stent examine compare medical treatment . Extent scar , viable myocardium infarct zone regional leave ventricular function assess cardiac magnetic resonance . Patients regional systolic leave ventricular dysfunction degree supply territory CTO vessel randomize either recanalization occlude coronary artery conservative therapy . It interest whether CTO patient improvement leave ventricular function late coronary reopening , regard high technical demand cost CTO recanalization .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>chronic total occlusion thrombolysis myocardial infarction ( TIMI ) 0 flow ( distal capillary reflow ) native coronary artery estimate reference vessel diameter 2.5 4.0 mm chronic total occlusion 4 week duration target vessel previously treat percutaneous coronary intervention target vessel must feasible stent implantation patient stable unstable angina pectoris positive functional study ischemia patient must 18 year age old female subject childbearing age must negative pregnancy test within 7 day procedure patient inform nature study agree provision an write informed consent approve Ethics Committee patient complies require postprocedure followup document leave ventricular function &lt; 30 % patient acute myocardial infarction ( &gt; 3x normal creatine kinase ( CK presence CKMB ) within 72 hour precede index procedure CK return normal limit time procedure patient know hypersensitivity contraindication aspirin , heparin , clopidogrel , stainless steel contrast medium adequately premedicated patient platelet count &lt; 100000 cells/mm3 &gt; 700000 cells/m3 , white blood cell count &lt; 3000 cells/mm3 document suspect liver disease patient history bleed diathesis coagulopathy patient suffer cerebrovascular accident transient ischemic attack within past 6 month active peptic ulcer upper gastrointestinal bleeding within prior 6 month patient comorbidity ( i.e . cancer congestive heart failure ) may cause patient noncompliant protocol , associate limited lifeexpectancy ( less 2 year ) target vessel contains intraluminal thrombus target vessel lesson show angiographic evidence severe calcification patient contraindication magnetic resonance imaging</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>chronic occlusion coronary artery</keyword>
	<keyword>leave ventricular function</keyword>
	<keyword>revascularisation</keyword>
</DOC>